Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Shanghai Junshi Biosciences Co Ltd a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies announced that the National Medical Products Administration
GSK plctoday announced positive headline results from the phase III clinical trials ANCHOR and ANCHOR which assessed the efficacy and safety of depemokimab versus placebo in adults with CRSwNP Both trials met their coprimary endpoints of a change fro...
XtalPi a global leader in AI drug discovery announced today a license agreement between Ailux Biologics a division of XtalPi Inc and Janssen Biotech IncJanssen a Johnson Johnson company on one of its proprietary biologics AI platforms Under the agre...
KeyBioscience and Eli Lilly and Company have agreed to extend their collaboration on the development of Dual Amylin Calcitonin Receptor Agonists DACRA a new class of potential treatments for obesity and related disorders
CanFite BioPharma Ltda biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases today announced the Companys oncology drug candidate Namodenoson has been granted Orphan Drug Des...
Daewoong Pharmaceuticalannounced on the th that they will present their cuttingedge drug delivery technologies including the worlds first microneedlebased drugs at CPHI Worldwide the worlds largest pharmaceutical and biotech exhibitionheld in Milan I...
Viatris Inca global healthcare company today announced positive topline results of its Phase study B in Japan evaluating the safety and efficacy of EFFEXOR venlafaxine in adults with generalized anxiety disorder GAD The study achieved its primary ob...
Johnson Johnson announced today it has successfully completed the acquisition of VWave Ltd a privatelyheld company focused on developing innovative treatment options for patients with heart failure VWave will operate as part of Johnson Johnson MedT...
GSK plctoday announced new data from the AReSVi Adult Respiratory Syncytial Virus phase III trial evaluating the efficacy of a single dose of Arexvy respiratory syncytial virus vaccine recombinant adjuvanted against lower respiratory tract disease LR...
Pierre Fabre Laboratories a global player in oncology and Scorpion Therapeutics Inc Scorpion a pioneering clinicalstage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision medicine today ann...
